Malkin D - Search Results

1

Towards an understanding of the role of p53 in adrenocortical carcinogenesis.

Wasserman JD, Zambetti GP, Malkin D. Wasserman JD, et al. Among authors: malkin d. Mol Cell Endocrinol. 2012 Mar 31;351(1):101-10. doi: 10.1016/j.mce.2011.09.010. Epub 2011 Sep 10. Mol Cell Endocrinol. 2012. PMID: 21930187 Free PMC article. Review.

2

The role of tumour suppressor genes in familial cancer.

Malkin D, Friend SH. Malkin D, et al. Semin Cancer Biol. 1992 Jun;3(3):121-30. Semin Cancer Biol. 1992. PMID: 1511155 Review.

3

p53 and the Li-Fraumeni syndrome.

Malkin D. Malkin D. Cancer Genet Cytogenet. 1993 Apr;66(2):83-92. doi: 10.1016/0165-4608(93)90233-c. Cancer Genet Cytogenet. 1993. PMID: 8500106 Review.

4

p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.

Quesnel S, Verselis S, Portwine C, Garber J, White M, Feunteun J, Malkin D, Li FP. Quesnel S, et al. Among authors: malkin d. Oncogene. 1999 Jul 8;18(27):3970-8. doi: 10.1038/sj.onc.1202783. Oncogene. 1999. PMID: 10435620

5

The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome.

Malkin D, Brown EJ, Zipursky A. Malkin D, et al. Cancer Genet Cytogenet. 2000 Jan 1;116(1):1-5. doi: 10.1016/s0165-4608(99)00072-2. Cancer Genet Cytogenet. 2000. PMID: 10616523

6

The role of p53 in human cancer.

Malkin D. Malkin D. J Neurooncol. 2001 Feb;51(3):231-43. doi: 10.1023/a:1010636426860. J Neurooncol. 2001. PMID: 11407595 Review.

7

Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.

Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Malkin D, et al. Oncogene. 2001 Jul 27;20(33):4441-9. doi: 10.1038/sj.onc.1204583. Oncogene. 2001. PMID: 11494139

8

Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.

Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D. Barlow JW, et al. Among authors: malkin d. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1403-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298965

9

Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin.

Ganjavi H, Gee M, Narendran A, Parkinson N, Krishnamoorthy M, Freedman MH, Malkin D. Ganjavi H, et al. Among authors: malkin d. Cancer Gene Ther. 2006 Apr;13(4):415-9. doi: 10.1038/sj.cgt.7700909. Cancer Gene Ther. 2006. PMID: 16211088

10

Hereditary cancer predisposition in children: genetic basis and clinical implications.

Strahm B, Malkin D. Strahm B, et al. Among authors: malkin d. Int J Cancer. 2006 Nov 1;119(9):2001-6. doi: 10.1002/ijc.21962. Int J Cancer. 2006. PMID: 16642469 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page